Breathing Disorders Treatment Market 2027 By Drug Class, Indication, Distribution Channel and Geography | The Insight Partners

Breathing Disorders Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Drug Class (Nasal Decongestant, Cough Suppressant, Non-Steroid Anti-Inflammatory Drugs (NSAIDS), Antibiotics, Others); Indication (Idiopathic Pulmonary Fibrosis, Cystic Fibrosis (CF), Asthma, Allergic Rhinitis, Chronic Obstructive Pulmonary Disease (COPD), Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

Report Code: TIPRE00015273 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Pharmaceutical and biotechnology drugs are used for the treatment of various conditions that affect the lungs. These medications cover an ambit of diseases that ranges from common cold to long-term cure diseases such as COPD and asthma. Breathing disorder treatments are available in various dosage forms that include inhalers, oral tablets, liquids, injections and others.

MARKET DYNAMICS

The breathing disorders treatment market is driving due to increasing incidence of COPD and other respiratory diseases, rising number of population engaged in tobacco smoking, others. In addition, several initiatives undertaken by various government and non-government organizations for research and investment into pulmonary drugs therapeutics is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Breathing Disorders Treatment Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of breathing disorders treatment market with detailed market segmentation by drug class, indication, and distribution channel. The breathing disorders treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in breathing disorders treatment market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The breathing disorders treatment market is segmented on the basis of drug class, indication, and distribution channel. Based on drug class, the market is segmented as nasal decongestant, cough suppressant, non-steroid anti-inflammatory drugs (NSAIDS), antibiotics, and others. On the basis of indication, the market is segmented into idiopathic pulmonary fibrosis, cystic fibrosis (CF), asthma, allergic rhinitis, chronic obstructive pulmonary disease (COPD), and others. On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the breathing disorders treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to2027with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The breathing disorders treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting breathing disorders treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the breathing disorders treatment market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the breathing disorders treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from breathing disorders treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for breathing disorders treatment in the global market. Below mentioned is the list of few companies engaged in the breathing disorders treatment market.

The report also includes the profiles of key players in breathing disorders treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •  Biogen
  •  Bayer AG
  •  Aurobindo Pharma
  •  Novartis AG
  •  Amgen
  •  F.Hoffmann La-Roche Ltd.
  •  Abbott
  •  Glaxosmithkline Plc
  •  AstraZeneca Plc
  •  Merck KGaA

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Breathing Disorders Treatment Market - By Drug Class
1.3.2 Breathing Disorders Treatment Market - By Indication
1.3.3 Breathing Disorders Treatment Market - By Distribution Channel
1.3.4 Breathing Disorders Treatment Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BREATHING DISORDERS TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BREATHING DISORDERS TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BREATHING DISORDERS TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. BREATHING DISORDERS TREATMENT - GLOBAL MARKET OVERVIEW
6.2. BREATHING DISORDERS TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. BREATHING DISORDERS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. NASAL DECONGESTANT
7.3.1. Overview
7.3.2. Nasal Decongestant Market Forecast and Analysis
7.4. COUGH SUPPRESSANT
7.4.1. Overview
7.4.2. Cough Suppressant Market Forecast and Analysis
7.5. NON-STEROID ANTI-INFLAMMATORY DRUGS (NSAIDS)
7.5.1. Overview
7.5.2. Non-Steroid Anti-Inflammatory Drugs (NSAIDS) Market Forecast and Analysis
7.6. ANTIBIOTICS
7.6.1. Overview
7.6.2. Antibiotics Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. BREATHING DISORDERS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. IDIOPATHIC PULMONARY FIBROSIS
8.3.1. Overview
8.3.2. Idiopathic Pulmonary Fibrosis Market Forecast and Analysis
8.4. CYSTIC FIBROSIS (CF)
8.4.1. Overview
8.4.2. Cystic Fibrosis (CF) Market Forecast and Analysis
8.5. ASTHMA
8.5.1. Overview
8.5.2. Asthma Market Forecast and Analysis
8.6. ALLERGIC RHINITIS
8.6.1. Overview
8.6.2. Allergic Rhinitis Market Forecast and Analysis
8.7. CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
8.7.1. Overview
8.7.2. Chronic Obstructive Pulmonary Disease (COPD) Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. BREATHING DISORDERS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
10. BREATHING DISORDERS TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Breathing Disorders Treatment Market Overview
10.1.2 North America Breathing Disorders Treatment Market Forecasts and Analysis
10.1.3 North America Breathing Disorders Treatment Market Forecasts and Analysis - By Drug Class
10.1.4 North America Breathing Disorders Treatment Market Forecasts and Analysis - By Indication
10.1.5 North America Breathing Disorders Treatment Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Breathing Disorders Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Breathing Disorders Treatment Market
10.1.6.1.1 United States Breathing Disorders Treatment Market by Drug Class
10.1.6.1.2 United States Breathing Disorders Treatment Market by Indication
10.1.6.1.3 United States Breathing Disorders Treatment Market by Distribution Channel
10.1.6.2 Canada Breathing Disorders Treatment Market
10.1.6.2.1 Canada Breathing Disorders Treatment Market by Drug Class
10.1.6.2.2 Canada Breathing Disorders Treatment Market by Indication
10.1.6.2.3 Canada Breathing Disorders Treatment Market by Distribution Channel
10.1.6.3 Mexico Breathing Disorders Treatment Market
10.1.6.3.1 Mexico Breathing Disorders Treatment Market by Drug Class
10.1.6.3.2 Mexico Breathing Disorders Treatment Market by Indication
10.1.6.3.3 Mexico Breathing Disorders Treatment Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Breathing Disorders Treatment Market Overview
10.2.2 Europe Breathing Disorders Treatment Market Forecasts and Analysis
10.2.3 Europe Breathing Disorders Treatment Market Forecasts and Analysis - By Drug Class
10.2.4 Europe Breathing Disorders Treatment Market Forecasts and Analysis - By Indication
10.2.5 Europe Breathing Disorders Treatment Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Breathing Disorders Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Breathing Disorders Treatment Market
10.2.6.1.1 Germany Breathing Disorders Treatment Market by Drug Class
10.2.6.1.2 Germany Breathing Disorders Treatment Market by Indication
10.2.6.1.3 Germany Breathing Disorders Treatment Market by Distribution Channel
10.2.6.2 France Breathing Disorders Treatment Market
10.2.6.2.1 France Breathing Disorders Treatment Market by Drug Class
10.2.6.2.2 France Breathing Disorders Treatment Market by Indication
10.2.6.2.3 France Breathing Disorders Treatment Market by Distribution Channel
10.2.6.3 Italy Breathing Disorders Treatment Market
10.2.6.3.1 Italy Breathing Disorders Treatment Market by Drug Class
10.2.6.3.2 Italy Breathing Disorders Treatment Market by Indication
10.2.6.3.3 Italy Breathing Disorders Treatment Market by Distribution Channel
10.2.6.4 Spain Breathing Disorders Treatment Market
10.2.6.4.1 Spain Breathing Disorders Treatment Market by Drug Class
10.2.6.4.2 Spain Breathing Disorders Treatment Market by Indication
10.2.6.4.3 Spain Breathing Disorders Treatment Market by Distribution Channel
10.2.6.5 United Kingdom Breathing Disorders Treatment Market
10.2.6.5.1 United Kingdom Breathing Disorders Treatment Market by Drug Class
10.2.6.5.2 United Kingdom Breathing Disorders Treatment Market by Indication
10.2.6.5.3 United Kingdom Breathing Disorders Treatment Market by Distribution Channel
10.2.6.6 Rest of Europe Breathing Disorders Treatment Market
10.2.6.6.1 Rest of Europe Breathing Disorders Treatment Market by Drug Class
10.2.6.6.2 Rest of Europe Breathing Disorders Treatment Market by Indication
10.2.6.6.3 Rest of Europe Breathing Disorders Treatment Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Breathing Disorders Treatment Market Overview
10.3.2 Asia-Pacific Breathing Disorders Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Breathing Disorders Treatment Market Forecasts and Analysis - By Drug Class
10.3.4 Asia-Pacific Breathing Disorders Treatment Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Breathing Disorders Treatment Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Breathing Disorders Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Breathing Disorders Treatment Market
10.3.6.1.1 Australia Breathing Disorders Treatment Market by Drug Class
10.3.6.1.2 Australia Breathing Disorders Treatment Market by Indication
10.3.6.1.3 Australia Breathing Disorders Treatment Market by Distribution Channel
10.3.6.2 China Breathing Disorders Treatment Market
10.3.6.2.1 China Breathing Disorders Treatment Market by Drug Class
10.3.6.2.2 China Breathing Disorders Treatment Market by Indication
10.3.6.2.3 China Breathing Disorders Treatment Market by Distribution Channel
10.3.6.3 India Breathing Disorders Treatment Market
10.3.6.3.1 India Breathing Disorders Treatment Market by Drug Class
10.3.6.3.2 India Breathing Disorders Treatment Market by Indication
10.3.6.3.3 India Breathing Disorders Treatment Market by Distribution Channel
10.3.6.4 Japan Breathing Disorders Treatment Market
10.3.6.4.1 Japan Breathing Disorders Treatment Market by Drug Class
10.3.6.4.2 Japan Breathing Disorders Treatment Market by Indication
10.3.6.4.3 Japan Breathing Disorders Treatment Market by Distribution Channel
10.3.6.5 South Korea Breathing Disorders Treatment Market
10.3.6.5.1 South Korea Breathing Disorders Treatment Market by Drug Class
10.3.6.5.2 South Korea Breathing Disorders Treatment Market by Indication
10.3.6.5.3 South Korea Breathing Disorders Treatment Market by Distribution Channel
10.3.6.6 Rest of Asia-Pacific Breathing Disorders Treatment Market
10.3.6.6.1 Rest of Asia-Pacific Breathing Disorders Treatment Market by Drug Class
10.3.6.6.2 Rest of Asia-Pacific Breathing Disorders Treatment Market by Indication
10.3.6.6.3 Rest of Asia-Pacific Breathing Disorders Treatment Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Breathing Disorders Treatment Market Overview
10.4.2 Middle East and Africa Breathing Disorders Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Breathing Disorders Treatment Market Forecasts and Analysis - By Drug Class
10.4.4 Middle East and Africa Breathing Disorders Treatment Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Breathing Disorders Treatment Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Breathing Disorders Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Breathing Disorders Treatment Market
10.4.6.1.1 South Africa Breathing Disorders Treatment Market by Drug Class
10.4.6.1.2 South Africa Breathing Disorders Treatment Market by Indication
10.4.6.1.3 South Africa Breathing Disorders Treatment Market by Distribution Channel
10.4.6.2 Saudi Arabia Breathing Disorders Treatment Market
10.4.6.2.1 Saudi Arabia Breathing Disorders Treatment Market by Drug Class
10.4.6.2.2 Saudi Arabia Breathing Disorders Treatment Market by Indication
10.4.6.2.3 Saudi Arabia Breathing Disorders Treatment Market by Distribution Channel
10.4.6.3 U.A.E Breathing Disorders Treatment Market
10.4.6.3.1 U.A.E Breathing Disorders Treatment Market by Drug Class
10.4.6.3.2 U.A.E Breathing Disorders Treatment Market by Indication
10.4.6.3.3 U.A.E Breathing Disorders Treatment Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa Breathing Disorders Treatment Market
10.4.6.4.1 Rest of Middle East and Africa Breathing Disorders Treatment Market by Drug Class
10.4.6.4.2 Rest of Middle East and Africa Breathing Disorders Treatment Market by Indication
10.4.6.4.3 Rest of Middle East and Africa Breathing Disorders Treatment Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Breathing Disorders Treatment Market Overview
10.5.2 South and Central America Breathing Disorders Treatment Market Forecasts and Analysis
10.5.3 South and Central America Breathing Disorders Treatment Market Forecasts and Analysis - By Drug Class
10.5.4 South and Central America Breathing Disorders Treatment Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Breathing Disorders Treatment Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Breathing Disorders Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Breathing Disorders Treatment Market
10.5.6.1.1 Brazil Breathing Disorders Treatment Market by Drug Class
10.5.6.1.2 Brazil Breathing Disorders Treatment Market by Indication
10.5.6.1.3 Brazil Breathing Disorders Treatment Market by Distribution Channel
10.5.6.2 Argentina Breathing Disorders Treatment Market
10.5.6.2.1 Argentina Breathing Disorders Treatment Market by Drug Class
10.5.6.2.2 Argentina Breathing Disorders Treatment Market by Indication
10.5.6.2.3 Argentina Breathing Disorders Treatment Market by Distribution Channel
10.5.6.3 Rest of South and Central America Breathing Disorders Treatment Market
10.5.6.3.1 Rest of South and Central America Breathing Disorders Treatment Market by Drug Class
10.5.6.3.2 Rest of South and Central America Breathing Disorders Treatment Market by Indication
10.5.6.3.3 Rest of South and Central America Breathing Disorders Treatment Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BREATHING DISORDERS TREATMENT MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. BREATHING DISORDERS TREATMENT MARKET, KEY COMPANY PROFILES
13.1. BIOGEN
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BAYER AG
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. AUROBINDO PHARMA
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. NOVARTIS AG
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. AMGEN
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. H.HOFFMANN LA-ROCHE LTD.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ABBOTT
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. GLAXOSMITHKLINE PLC
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. ASTRAZENECA PLC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. MERCK KGAA
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Biogen
2. Bayer AG
3. Aurobindo Pharma
4. Novartis AG
5. Amgen
6. F.Hoffmann La-Roche Ltd.
7. Abbott
8. Glaxosmithkline Plc
9. AstraZeneca Plc
10. Merck KGaA
TIPRE00015273
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking